Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Amortizatization of Intangibles: 2018-2024

Historic Amortizatization of Intangibles for Kiniksa Pharmaceuticals International (KNSA) over the last 7 years, with Dec 2024 value amounting to -$441,000.

  • Kiniksa Pharmaceuticals International's Amortizatization of Intangibles fell 223.82% to -$603,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$833,000, marking a year-over-year decrease of 223.59%. This contributed to the annual value of -$441,000 for FY2024, which is 141.29% down from last year.
  • Per Kiniksa Pharmaceuticals International's latest filing, its Amortizatization of Intangibles stood at -$441,000 for FY2024, which was down 141.29% from $1.1 million recorded in FY2023.
  • In the past 5 years, Kiniksa Pharmaceuticals International's Amortizatization of Intangibles ranged from a high of $1.1 million in FY2023 and a low of -$664,000 during FY2021.
  • Its 3-year average for Amortizatization of Intangibles is $236,333, with a median of $82,000 in 2022.
  • In the last 5 years, Kiniksa Pharmaceuticals International's Amortizatization of Intangibles crashed by 439.84% in 2021 and then surged by 1,202.44% in 2023.
  • Yearly analysis of 5 years shows Kiniksa Pharmaceuticals International's Amortizatization of Intangibles stood at -$123,000 in 2020, then tumbled by 439.84% to -$664,000 in 2021, then surged by 112.35% to $82,000 in 2022, then surged by 1,202.44% to $1.1 million in 2023, then tumbled by 141.29% to -$441,000 in 2024.